NCT03927820
Active, not recruiting
Not Applicable
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
Vanderbilt University Medical Center1 site in 1 country914 target enrollmentStarted: September 9, 2019Last updated:
Overview
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Enrollment
- 914
- Locations
- 1
- Primary Endpoint
- Time to either hospital readmission or ER visit
Overview
Brief Summary
The goal of this study is to assess the impact of pharmacist-led benefits investigations and application of clinical practice guidelines on patient access to inhalers and time to hospital readmission or Emergency Department (ED) visit.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Health Services Research
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Adult patient admitted to Vanderbilt University Medical Center (VUMC) (excluding surgery services)
- •on a long acting inhaler or prescribed a long acting inhaler during admission.
Exclusion Criteria
- •Diagnosis of cystic fibrosis
- •Diagnosis of graft versus host disease (GVHD)
- •no medication insurance
- •discharge to any post-acute care facility or inpatient hospice
- •death during hospitalization
Outcomes
Primary Outcomes
Time to either hospital readmission or ER visit
Time Frame: 6 months
Combined time (days) to either hospital readmission or emergency department visit after hospitalization (all outcomes measured at 6 months post-discharge with a 3 month interim analysis)
Secondary Outcomes
- frequency of prescribed inhaler at discharge(6 months)
- frequency of hospital readmissions(6 months)
- frequency of short course prescription of oral steroid(6 months)
- Frequency of ED visit(6 months)
- time to 1st ED visit (days)(6 months)
- time to 1st readmission (days)(6 months)
Investigators
Tate Davis
Clinical Pharmacist
Vanderbilt University Medical Center
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Pharmacist Interventions in Rural Elderly Warfarin PatientsAtrial FibrillationThrombosisCardiac FailureHemorrhageNCT03212898Slaven Falamić131
Completed
Not Applicable
The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy SettingHerpes ZosterNCT00689013University of Tennessee205
Not yet recruiting
Not Applicable
Impact of Hospital Pharmacist Intervention on Medication Management in Dialysis PatientsRenal DialysisHealth Literacy LevelKidney Disease, ChronicNCT06692231Centre Hospitalier de Vichy70
Completed
Not Applicable
Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorders (PLI-MOUD)Opioid Use DisorderOverdoseNCT05776823University of Arkansas267
Completed
Not Applicable
Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease PatientsChronic Kidney DiseaseNCT06071065Hamdard University130